These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10334672)

  • 1. New epoetin molecules and novel therapeutic approaches.
    Barbone FP; Johnson DL; Farrell FX; Collins A; Middleton SA; McMahon FJ; Tullai J; Jolliffe LK
    Nephrol Dial Transplant; 1999; 14 Suppl 2():80-4. PubMed ID: 10334672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.
    Yi T; Zhang J; Miura O; Ihle JN
    Blood; 1995 Jan; 85(1):87-95. PubMed ID: 7528577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity.
    Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Kroon D; Freedy J; Zivin RA; Mulcahy LS; Jolliffe LK
    Chem Biol; 1997 Dec; 4(12):939-50. PubMed ID: 9427659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1.
    Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Hoey K; Livnah O; Wrighton NC; Middleton SA; Loughney DA; Stura EA; Dower WJ; Mulcahy LS; Wilson IA; Jolliffe LK
    Biochemistry; 1998 Mar; 37(11):3699-710. PubMed ID: 9521688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
    Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK
    J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
    Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA
    Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a small molecule erythropoietin mimetic.
    Guarnieri F
    Methods Mol Biol; 2015; 1289():185-210. PubMed ID: 25709041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
    Livnah O; Stura EA; Johnson DL; Middleton SA; Mulcahy LS; Wrighton NC; Dower WJ; Jolliffe LK; Wilson IA
    Science; 1996 Jul; 273(5274):464-71. PubMed ID: 8662530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities.
    Kessler C; Greindl A; Breuer B; Haberl U; Rybka A; Emgenbroich M; Frank HG; Pötgens AJ
    Cytokine; 2012 Feb; 57(2):226-37. PubMed ID: 22142701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased potency of an erythropoietin peptide mimetic through covalent dimerization.
    Wrighton NC; Balasubramanian P; Barbone FP; Kashyap AK; Farrell FX; Jolliffe LK; Barrett RW; Dower WJ
    Nat Biotechnol; 1997 Nov; 15(12):1261-5. PubMed ID: 9359108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
    Guarnieri F
    Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling.
    Cohen J; Oren-Young L; Klingmuller U; Neumann D
    Biochem J; 2004 Jan; 377(Pt 2):517-24. PubMed ID: 14527337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of new multimeric erythropoietin receptor agonists.
    Vadas O; Hartley O; Rose K
    Biopolymers; 2008; 90(4):496-502. PubMed ID: 18273892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.
    Cohen J; Altaratz H; Zick Y; Klingmüller U; Neumann D
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):391-7. PubMed ID: 9359406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.
    Kawakami M; Iwasaki S; Sato K; Takahashi M
    Biochem Biophys Res Commun; 2000 Dec; 279(1):293-7. PubMed ID: 11112455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtraction cloning and initial characterization of novel epo-immediate response genes.
    Gregory RC; Lord KA; Panek LB; Gaines P; Dillon SB; Wojchowski DM
    Cytokine; 2000 Jul; 12(7):845-57. PubMed ID: 10880228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS.
    Vogel M; Thomas A; Schänzer W; Thevis M
    J Am Soc Mass Spectrom; 2015 Sep; 26(9):1617-25. PubMed ID: 26122516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.